We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Fast-Tracks Third Duchenne Treatment This Year
FDA Fast-Tracks Third Duchenne Treatment This Year
The FDA has fast-tracked the third potential treatment for Duchenne Muscular Dystrophy this year, granting the designation to New Jersey-based Tarix Orphan for its TXA127.